To see the effect of 2 medicines namely panchasama churna and kshara basti in the treatment of disease Amavata(Rheumatoid Arthritis)Â

A Randomized Comparative Clinical Study To Evaluate The Efficacy Of Panchsamachurna And Ksharbasti In The Management Of Amavata W.S.R. To Rheumatoid Arthritis

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2022/04/042053

Enrollment

Registered

2022-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M05- Rheumatoid arthritis with rheumatoid factor

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1 Patient willing to participate in the trial. 2 The patients between the age group of 18 to 60 years. 3 Patients having classical features of Amavata like Angamarda(malaise), Aruchi(Anorexia), Trishna(excessive thirst), Alasya(laziness), Gaurava(heaviness of body), Jwara(fever), Apaka(indigestion), Angashoonata(swelling). 4 Pt. who is taking anti inflammatory(analgesics) will be included after a washout period of 7days provided they are diagnosed with RA in last 1 year. 5 The patients should fulfil the 2010 ACR(American College of Rheumatology) EULAR (European League Against Rheumatism) criteria for rheumatoid arthritis.

Exclusion criteria

Exclusion criteria: 1 Patients having Severe crippling bone deformity. 2 Pt. who are on DMRDs and Biologicals are not included in study. 3 Patients having another type of arthropathy such as Neoplasm of spine, Gout, Ankylosing spondylitis etc. 4 Patients having associated Cardiac disease, Pulmonary Tuberculosis. 5 Patients with genetic and endocrinal disorder, chronic disorder like Paralysis, Cancer, Renal failure, Hepatic failure. 6 H/O of hypersensitivity of any trial drug. Patients taking antibiotic therapy for any systemic illness within 2 months. 7 Pregnant women and lactating mother.

Design outcomes

Primary

Measure	Time frame
1 The assessment of effect of Panchsama churna on the cardinal features 2 The assessment of effect of Ksharbasti karma 3 The assessment of effect of Ksharbasti karma along with Panchsama churna 4 Improvement in subjective parameters like 1 Pain in joints 2 swelling in joints 3 Tenderness of joints 4 Stiffness of jointsTimepoint: At baseline and after 12 weeks	—

Secondary

Measure	Time frame
Assessment will be done clinically on basis of improvement in objective parameters like RA Factor, CRP, ESR and Anti-CCP.Timepoint: At baseline and after 12 weeks	—

Countries

India

Contacts

Public ContactDr SUJATA YADAV

Ayurvedic and Unani Tibbia College Hospital

sujatakcdelhi@gmail.com9354925030

Outcome results